2[1]Aso Y, Fujiwara Y, Tayama K, et al. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. Clin Chim Acta, 2000, 301: 135-145.
3[2]Knobl P, Schernthaner G, Schnack C, et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 1993, 36: 1045-1050.
2Frank P, Kay H, Beate K, et al. Rosiglitazone Improves Glomerular Hyperfihration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephlopathy in Patients [J]. Diabetes, 2005, 54 (7): 2206-2211.
3Sarafidis P, Lasaridis A, Nilsson P, et al. The elect of rosiglitazone on urine albumin excretion in patients with type 2diabetes mellitus and hypertension[J]. Am J Hypertens, 2005, 18 (2Pt1) : 227-234.
4Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats [J]. Diabetes, 2000, 49 (6) : 1022-1032.
5Frank P, Kay H, Beate K, et al. Rosiglitazone Improves Glomerular Hyperfihration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephlopathy in Patients [J]. Diabetes. 2005, 54 (7): 2206-2211.
